Prosus’s red report card for underperformers Byju’s, PharmEasy

This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.

30 November, 20231 min
0
Prosus’s red report card for underperformers Byju’s, PharmEasy

You may also like

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.

Business
Story image

Abu Dhabi’s $16 billion push to become a finance magnet

Highlights from Abu Dhabi Finance Week, Qatar’s new (and bolder) AI ambition and the bid for Warner Bros. Discovery.

Business
Story image

The pressures on Tadawul index and Saudi’s attempt to fix them

Saudi Arabia’s primary market has been facing challenges despite a rather busy IPO pipeline.